Skip to content

Three Rivers Dermatology, LLC

Clinician group · Fort Wayne, IN

100%

Psoriasis: Clinical Response to Systemic Medications

2024 · Higher is better

100%

Melanoma: – Appropriate Surgical Margins

2024 · Higher is better

CMS files are dated Sep 10, 2026 to Oct 15, 2026Model ml-4Coverage and freshness

Outcome

100%Psoriasis: Clinical Response to Systemic Medications

Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026

Psoriasis: Clinical Response to Systemic Medications, 2024. Higher is better. It does not predict your own result.

  • Not risk-adjusted
  • Not an overall doctor rating
  • Benchmark 100
  • Exact collection/stratum/entity level only, not an overall doctor rating
  • Reporting year 2024
  • 556 eligible cases
  • 5 of 5 stars (CMS)
  • CMS
  • Published 10 Sep 2026
What this measures

Percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician-or patient- reported disease activity levels.

It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase patient satisfaction with and adherence to treatment.

Published stratum: overall.

Exact public stratum retained; no pooling with other strata.

2024 reporting year.

Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.

Original published percentage; no scaling or reconstructed numerator.

Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.

Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_410_MIPSCQM.pdf.

Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.

100%Melanoma: – Appropriate Surgical Margins

Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026

Melanoma: – Appropriate Surgical Margins, 2024. Higher is better.

  • Not risk-adjusted
  • Reporting year 2024
  • 24 eligible cases
  • CMS
  • Published 10 Sep 2026
What this measures

Percentage of primary excisional surgeries for melanoma or melanoma in situ with Breslow depth and appropriate surgical margins per the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology- Melanoma (NCCN Guideline).

Published stratum: overall.

Exact public stratum retained; no pooling with other strata.

2024 reporting year.

Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.

Original published percentage; no scaling or reconstructed numerator.

Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.

Definition: CMSgov/qpp-measures-data 2024.

Published eligible intermediateOutcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.

It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.

Missing values stay missing. A grey value means the publisher reported no figure, often because there were too few cases. It does not mean the result is bad.

Experience

Procedure volumeGroup experience

The reviewed data do not publish this result.

Group and hospital

Group resultMeasured separately

Loading…

Offices

1
5650 Coventry Ln

Fort Wayne, IN 46804-7140

Report name

Sources and methods
PY 2024 Group Public Reporting: MIPS Measures and AttestationsGroup results · Name, specialty and offices

data.cms.gov · released 10 Sep 2026

CMS Doctors and Clinicians National Downloadable FileName, specialty and offices

data.cms.gov · released 12 Nov 2026

Publisher notesAs published

Official public federal aggregate data; cite CMS, no endorsement. Clinical periods are separate from publisher release and operational fetch dates. No government endorsement.

Missing evidence is not zero and does not mean poor care. Source list · Coverage and freshness